ACRO Biomedical Co Ltd. Stock Analysis ACBM
Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. The company is headquartered in Fishers, Indiana. The company went IPO on 2016-06-23. The firm is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle. The firm's business consists of selling cordyceps related products that is used in traditional Chinese medicine. Cordyceps is a fungus which is a combination of a caterpillar and a fungus, which is found at altitudes above 4500 meters (m) in Sikkim. The firm is engaged in the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers. The company sells products in bulk to companies who may use the Company's products as ingredients in their products or sell the products they purchase from the Company to their own customers.
Read More ACRO Biomedical Co Ltd (ACBM) Chart
Key Statistics of ACRO Biomedical Co Ltd (ACBM)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.03Volume
155.00P/E Ratio (TTM)
-52 Week Range
Market Cap
1.56MAvg. Volume
155.00Dividend Yield
-Financial Metrics & Statements of ACRO Biomedical Co Ltd (ACBM)
FAQ's for ACRO Biomedical Co Ltd (ACBM)
- According to Musaffa’s Shariah screening methodology, ACRO Biomedical Co Ltd (ACBM) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.